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Abstract
Background: It is unclear whether the loss of physiological complexity during the aging process is due to genetic variations.
The APOE gene has been studied extensively in regard to its relationship with aging-associated medical illness. We
hypothesize that diminished physiological complexity, as measured by heart rate variability, is influenced by polymorphisms
in the APOE allele among elderly individuals.
Methodology/Principal Findings: A total of 102 robust, non-demented, elderly subjects with normal functions of daily
activities participated in this study (97 males and 5 females, aged 79.264.4 years, range 72–92 years). Among these
individuals, the following two APOE genotypes were represented: e4 non-carriers (n=87, 85.3%) and e4 carriers (n=15,
14.7%). Multi-scale entropy (MSE), an analysis used in quantifying complexity for nonlinear time series, was employed to
analyze heart-rate dynamics. Reduced physiological complexity, as measured by MSE, was significantly associated with the
presence of the APOE e4 allele in healthy elderly subjects, as compared to APOE e4 allele non-carriers (24.665.5 versus
28.965.2, F=9.429, p=0.003, respectively).
Conclusions/Significance: This finding suggests a role for the APOE gene in the diminished physiological complexity seen
in elderly populations.
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Introduction
Biologically, the physiological output of the human body
emerges from interactions among a variety of factors, ranging
from genes to organs to the environment [1]. These interactions,
under healthy conditions, are essential for responses to environ-
mental stress and are evident in both behavioral and physiological
complexity, such as daily activities, heart rate, blood pressure, and
brain electrical activities. In contrast, aging and illness are
associated with degraded and/or decoupled regulatory networks
and often result in the generation of less complex outputs [2,3].
The loss of complexity is therefore, to a large extent, the hallmark
of illness and the aging process [3,4]. This reduced complexity can
be quantified both behaviorally [4] and physiologically, such as
through analysis of heart rate variability (HRV) [3]. However,
despite a growing body of clinical and basic science research of
applying complexity theory in aging and illness [2,3,4,5], the
relationship between the loss of such complexity and a genetic
predisposition is still unclear.
The apolipoprotein-E (APOE) gene has been studied extensively
in regard to its relationship to aging-associated medical illness,
including cardiovascular disease [6,7,8,9], geriatric cognitive
decline [10,11], and late-onset Alzheimer’s disease [12]. The
impact of the APOE polymorphism on the increased risk of a
variety of medical illnesses might lead to a reduced life span and
decreased adaptability of affected individuals to stress. These
separate lines of evidence lead to our hypothesis that variants of
the APOE gene (e.g., the e4 allele) may potentially reduce
physiological complexity in an affected individual, even before the
onset of certain medical illness related to APOE variants.
Therefore, in the present study, we applied a multiscale entropy
(MSE) analysis to examine effects of the APOE genotypes on heart
rate dynamics in a cohort of robust elderly adults.
Results
Descriptive statistics are summarized in Table 1. Clinical
characteristics were not different between the APOE e4-negative
and e4-positive groups, except that the gender distribution was
unbalanced between two groups (male, %: 97.7 vs. 80.0, p=0.02,
respectively). A comparison of representative interbeat interval time
series and MSE analysis between an APOE e4-negative and an
APOE e4-positive subject is shown in Figure 1. There were no
significant differences in conventional HRV measures between two
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e7733Figure 1. A comparison of a representative interbeat interval time series and analysis of multiscale entropy (MSE) between an
APOE e4-negative subject (top panels) and an APOE e4-positive subject (bottom panels). Time series length is 30 minutes. The APOE e4-
negative subject showed multiscale organizations in fluctuations of interbeat intervals, whereas a relatively monotonic oscillation was seen in the
interbeat interval time series obtained from an APOE e4-positive subject. By considering the impact of scale on entropy calculations, the sample
entropy values for the APOE e4-negative subject is higher than that for the APOE e4-positive subject for scales larger than two. Of note, the sum of
MSE from scale factor 1 to 20 was 28.3 for the APOE e4-negative subject and 17.3 for the APOE e4-positive subject.
doi:10.1371/journal.pone.0007733.g001
Table 1. Demographics and clinical characteristics.
Characteristics APOE e4-negative N=87 APOE e4-positive N=15 to rx
2 p
Age, year 79.164.4 79.464.2 20.222 0.825
Male gender, n (%) 85 (97.7) 12 (80.0) 5.22 0.022
Education, year 7.264.3 7.165.5 0.106 0.916
Body mass index, kg/m
2 23.863.1 24.863.0 21.068 0.289
Hypertension, n (%) 44 (50.6) 9 (60.0) 0.16 0.689
Diabetes, n (%) 10 (11.5) 1 (6.7) 0.01 0.920
Stroke, n (%) 6 (6.9) 1 (6.7) 0.27 0.603
Current smoker, n (%) 22 (25.3) 2 (13.3) 0.46 0.498
Systolic blood pressure, mmHg 145621 141612 0.633 0.528
Diastolic blood pressure, mmHg 78611 71611 1.738 0.086
White blood cell count, 10
3/mm
3 7.362.9 7.562.3 20.151 0.881
Hemoglobin, mg/dL 14.461.8 14.761.5 20.591 0.556
Fasting glucose, mg/dL 89.7615.8 89.0613.1 0.136 0.892
Total cholesterol, mg/dL 194.7648.6 182.2619.3 0.839 0.404
Triglycerides, mg/dL 120.5664.9 112.2656.8 0.4031 0.688
Mini-mental state examination, score (0–30) 27.962.1 27.362.0 0.974 0.332
Values are mean 6 standard deviation unless otherwise noted.
Categorical data are compared by chi-square tests, two tailed; all other p values are by Student’s t test, two tailed.
doi:10.1371/journal.pone.0007733.t001
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the MSE and conventional HRV indices. Significantly lower values
of MSE were found in the e4-positive group compared to e4-negative
group (24.665.5 vs. 28.965.2, F=9.429, p=0.003, respectively). No
significant MSE by ANCOVA covarying for age or clinical
parameters interaction effect was found. Figure 2 shows the
comparison of the MSE analysis for the entire study cohort by the
APOE e4 genotype at different time scales. For scales ranging from 3
to 13 (equal to interbeat interval time series of 10 to 40 heartbeats),
the sample entropy values were significantly lower (t-test, p,0.01) for
the group of APOE e4-positive,ascomparedtothegroupwithoutthe
APOE e4a l l e l e .
Discussion
Consistent with our hypothesis, the key finding of this study is
that reduced physiological complexity, as measured by multi-scale
entropy analysis, is associated with the APOE e4 allele in this
robust, aged population. The concept of loss of physiological
complexity in illness and during the aging process has been
hypothesized by several literature sources [3,4,13]. Degeneration
of the control mechanisms by illness and aging may lead to a
breakdown of coupling between physiological components and
thus result in the loss of complexity in heart rate dynamics [3].
Moreover, the lack of associations between MSE and other time-
frequency HRV measures indicates that MSE contains new
information (complexity) which was not quantified by convention-
al HRV indices. The findings of a relationship between the APOE
e4 allele and reduced physiological complexity at different time
scales suggest that variants of the APOE gene may affect the
integrity of the physiological system during the aging process.
While the exact mechanism of how the APOE e4 allele affects
physiological functions is unclear, degeneration of overall brain
functions associated with the APOE e4 allele [14,15,16,17], which
further results in decoupling between physiological control
systems, is a possible mechanism underlying the association
between APOE e4 allele and reduced physiological complexity.
The present study employed a nonlinear method adapted from
complexity theory, multi-scale entropy, to detect changes in
physiological complexity in an aged population. Cardiovascular
signals are largely analyzed using traditional time and frequency
domain measures. However, such measures fail to account for
important properties related to multi-scale organization and
nonequilibrium dynamics [3]. The complementary role of
complexity analysis is, therefore, an important tool to quantify
the nonlinear properties of physiological signals. Of note, reduced
complexity (e.g., fractal properties) have been implicated in the
risk of fatal cardiac arrhythmia, increased mortality, or poor
prognosis in cardiovascular diseases [18,19,20,21,22]. Our find-
ings of a relationship between reduced physiological complexity
and the APOE e4 allele is in line with the observation that APOE
e4 increases the risk of cardiovascular events in the long run [7,8].
Limited studies have shown procedures/exercise (e.g., meditation
or Tai-Chi exercise) that are able to increase vagal tone could have
protective effect on heart functions [23,24]. However, it’s not clear
whether these preventive means also alter the physiological
complexity. Therefore, further research is warranted to examine
if an appropriate treatment/prevention could compensate the
adverse impact of APOE e4 allele on physiologic functions.
There are limitations to this study. First, an evaluation of
cardiovascular function was not done and, thus, we cannot exclude
the possibility that subjects with this genetic finding also had occult
cardiovascular disease. Second, the possibility of selection bias
cannot be excluded due to the relatively small sample of subjects
and biased gender distribution towards the male gender (majority
of study subjects were veterans). Prior reports have shown that
gender may modulate the association between APOE gene and
related neuropathology [9,25,26], and therefore may potentially
affect the result of HRV analysis. Gender effect should be factored
in the future study. Third, as the study design was cross-sectional,
we cannot directly evaluate the long-term impact of the APOE
polymorphism on the physiological complexity and incidence of
cardiovascular diseases. A prospective study with a larger
population should be done to address this issue. Finally, interbeat
interval time series obtained from this aged population also posed
a challenge to HRV analysis as ectopic heartbeats or cardiac
arrhythmia (e.g., atrial fibrillation) are more common in elderly
populations. However, the subjects in the present study were
Table 2. Heart-rate variability characteristics.
Variable APOE e4-negative N=87 APOE e4-positive N=15 Fp
Time Domain Measure
Mean heart rate, beat/min 77.9616.0 80.9616.6 0.454 0.502
Standard deviation of normal interbeat intervals, ms 70.3632.4 72.1627.8 0.027 0.871
Root mean square successive difference between adjacent
normal interbeat intervals, ms
35.0625.1 31.6617.5 0.284 0.595
Percentage of adjacent normal interbeat intervals that varied by
greater than 50 ms, %
12.7618.0 8.068.8 0.991 0.322
Frequency Domain Measure
Very-low-frequency power, ln(ms
2/Hz) 7.9460.88 7.8860.93 0.079 0.779
Low-frequency power, ln(ms
2/Hz) 6.4161.07 6.2160.94 0.491 0.485
High-frequency power, ln(ms
2/Hz) 6.1361.40 6.0261.14 0.102 0.750
Low-frequency/high-frequency power, ln(ms
2/Hz) 2.0561.35 1.8761.25 0.206 0.651
Complexity Measure
Multiscale entropy, sum of sample entropy from scale factor 1 to 20 28.965.2 24.665.5 9.429 0.003
Values are mean 6 standard deviation unless otherwise noted.
Power spectral estimates were log transformed due to skewed distributions. F ratios from analyses of covariance, controlling for age and clinical parameters.
doi:10.1371/journal.pone.0007733.t002
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permitting the feasibility of applying HRV analysis to these aged
individuals.
In conclusion, reduced physiological complexity, as measured
by complexity analysis, was significantly associated with the
presence of the APOE e4 allele in healthy elderly subjects. This
observation may provide implications for understanding the role of
genetic predisposition in physiological aging. Further large-scale
research is warranted to investigate the interactions between
genes, physiological functioning, and the environment in the
elderly.
Materials and Methods
Ethics Statement
All subjects gave written informed consent before commence-
ment of the study. The protocol was approved by the Institutional
Review Board of the Taipei Veterans General Hospital.
Study Sample
A total of 184 elderly Chinese-Han elderly volunteers were
screened from a public veterans housing (N=161) and a local
elderly housing (N=22) in the community. Of these subjects, 113
were successfully contacted for ambulatory electrocardiogram
(ECG) monitoring. Each subject’s history of medical disease,
psychiatric illness, and medication use was evaluated carefully.
Evaluation of the psychiatric history and of cognitive functioning
was conducted by a psychiatrist. In addition, each subject
underwent a basic physical examination and laboratory testing
in order to gather data on clinical parameters. Subjects were
screened and excluded if they had acute or major medical diseases
(e.g., malignancy, heart failure, or infection), severe cardiac
arrhythmia or frequent ectopic heartbeats, dementia (defined by
clinical dementia rating scale .0.5), or a history of mental illness.
Subjects were also excluded if they took medication with
documented effects on the autonomic nervous system (e.g., beta-
blockers). Of these 113 subjects, eleven were further excluded
based on the above criteria. The final study sample consisted of
102 robust, non-demented elderly subjects with normal functions
of daily activities (97 males and 5 females, aged 79.264.4 years,
range 72–92 years).
Laboratory Methods and ECG Monitoring
APOE genotyping was determined using PCR-RFLP, accord-
ing to the procedure reported previously [27]. The studies of
APOE and cognitive functions as well as heart rate variability and
cognitive functions has been reported elsewhere [28,29]. Of the
102 subjects, there were four genotypes: e2/e2 (n=1, 1.0%), e2/
e3 (n=14, 13.7%), e3/e3 (n=72, 70.6%), and e3/e4 (n=15,
14.7%). When the sample was stratified according to the presence
of the e4 allele, 15 (14.7%) were e4 carriers compared with 87
(85.3%) non-e4 carriers. The frequency of e4 allele was
comparable with prior studies worldwide based on the community
sample (7.9%–16.5%) [30,31,32,33,34,35]. These subjects then
underwent two-hour electrocardiogram (ECG) monitoring using a
Holter monitor (MyECG E3-80 Portable Recorder, Microstar
Inc., Taipei, Taiwan). All ECG monitoring took place in the
daytime and participants were asked to stay in the resting state and
to avoid smoking and drinking alcoholic beverages before the
experimental procedures.
The Holter device continuously recorded three channels of
ECG signals at a sampling rate of 250 Hz. The ECG signals were
then processed and analyzed by an open source of HRV
algorithms [36]. Briefly, after detecting the QRS complex on
ECG by locating the R apex, the interbeat interval data was
automatically calculated as the time interval between two
consecutive R peaks (R-R interval). All beat annotations were
carefully checked to avoid erroneous detections or missed beats.
Analysis of Conventional Heart-Rate Variability
Conventional time and frequency domain HRV measures are
employed. Time domain measures of HRV include the mean
heart rate and standard deviation of the normal interbeat intervals
(SDNN), the root mean square successive difference between
adjacent normal interbeat intervals (RMSSD), and the percentage
of adjacent intervals that varied by greater than 50 ms (pNN50)
[37]. Spectral HRV measures [38] include high-frequency power
(0.15–0.40 Hz), low-frequency power (0.04–0.15 Hz), and very-
low-frequency power (0.003–0.04 Hz). Briefly, the RMSSD and
pNN50 measure the short-term variation of interbeat intervals,
which is mainly modulated by parasympathetic innervation [39].
Low-frequency power is suggested to be modulated by both
sympathetic and parasympathetic activities, whereas high-frequen-
cy power is mainly modulated by parasympathetic activity [40,41].
The low-frequency/high-frequency ratio was computed as a
measure of the sympathovagal balance toward sympathetic activity
[38,42].
Analysis of Physiological Complexity
Physiological signals under healthy conditions typically exhibit
multi-scale variability, long-range correlations, and non-linearity
[43]. Traditional complexity measurements are based on the
concept of entropy which quantifes the regularity (orderliness) of a
time series. Entropy increases with the degree of disorder and is
Figure 2. Multiscale entropy analysis by APOE e4 genotype.
Multiscale entropy was derived from two-hours of interbeat interval
time series. Symbols represent mean values of entropy for each group
and the bars represent the standard error. Parameters of sample
entropy calculation are m=2 and r=0.15. The sample entropy values
for subjects with APOE e4 allele are significantly lower (p,0.01) on
scales between 3 and 13, which are equal to oscillations at period
around 10 to 40 heartbeats. p values were computed using Student’s t-
test at each scale factor.
doi:10.1371/journal.pone.0007733.g002
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in entropy may not always be associated with an increase in
dynamical complexity. For instance, a randomized surrogate time
series has higher entropy than the original time series, despite the
process of generating the surrogate data destroys correlations and
degrades the information content of the original signal. A
biologically meaningful complexity measure has been proposed
by measuring the entropy over multiple time scales inherent in
physiologic signals, termed multiscale entropy (MSE) [44]. MSE
was computed over the interbeat interval data using publicly
available algorithms from the PhysioNet [36,44]. The algorithm of
MSE is as follows: Given a one-dimensional discrete time series,
{x1,…, xi;…,xN}, we construct consecutive coarse-grained time
series, {y
(t)}, determined by the scale factor, t, according to the
equation: y
t ðÞ
j ~1=t
Pjt
i~ j{1 ðÞ tz1Xi,1 !j!N/t. The length of
each coarse-grained time series is equal to the length of the
original time series divided by the scale factor, t. For scale one, the
time series is simply the original time series. We then calculate an
entropy measure (sample entropy) for each coarse-grained time
series and plot it as a function of the scale factortt. The procedure
and calculation of the MSE is summerized as following three steps:
1) construction of coarse-grained time series, 2) quantification of
the sample entropy of each coarse-grained time series, and 3)
summation of the sample entropy values over a range of scales. In
the present study, sample entropy was calculated using a pattern
length (m) of 2 and a similarity factor (r) of 0.15. The sum of
sample entropy over all scale factors from 1 to 20 was computed
for each subject and used to represent MSE in subsequent
analyses. Of note, to reduce the non-stationarity beyond the
maximum time scale detected by the MSE method (i.e., at scale
20, MSE can detect oscillation at the maximum of time period
covering 61 heartbeats), interbeat interval time series was pre-
detrended using the empirical mode decomposition method
[45,46].
Statistical Analysis
We performed allele and genotype frequency and Hardy-
Weinberg equilibrium tests for each APOE genotype. Chi-square
tests were used to compare categorical variables. Student’s t-test
was used to test for differences in demographic and clinical
measures between APOE e4 carriers and non-carriers. Analysis of
covariance (ANCOVA) was employed to determine group
differences for the HRV variables, controlling for age and clinical
parameters effects in this study sample. Partial correlation analysis
was applied, controlling for age and clinical measures, to
determine the associations between conventional HRV indices
and the MSE measure. A more rigorous p-value of less than 0.01
(two-tailed) for the nature of association study was required for
statistical significance. Based on prior literatures of applying MSE
in healthy elderly subjects [44,47], we estimated the total sample
size to be at least 94 by assuming power of 80%, 1% significance
level, minimum expected difference of 5 and estimated standard
deviation of 5.
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